Subscription momentum for the CCUS industry leader, Shougang LANZA (02553), continues to build after its initial public offering launch on May 26. As of 4:00 PM on May 27, data from J.L. Financial indicates that brokers have extended margin financing of HK$2.486 billion for Shougang LANZA's shares. Against a public offering fundraising target of HK$68.4 million, this represents an oversubscription of approximately 36.34 times. Among brokers, Futu Securities currently leads with HK$1.365 billion in margin financing, followed by Tiger Brokers and Phillip Securities, which recorded HK$231 million and HK$200 million, respectively, highlighting the dominant participation of key brokers.

The IPO subscription period for Shougang LANZA runs from May 26 to 29. The company is offering 40 million H shares globally, with 10% allocated to the Hong Kong public offering (subject to reallocation) and 90% to the international offering. A 15% over-allotment option is also in place. The offer price is set between HK$14.60 and HK$17.10 per share, with a board lot size of 200 shares. Trading on the Hong Kong Stock Exchange is expected to commence at 9:00 AM on June 3.

As the first company in the CCUS (Carbon Capture, Utilization, and Storage) sector to commercialize and scale low-carbon products using synthetic biology technology, Shougang LANZA holds a dominant global market share of 58.4% based on projected 2025 revenue. The company possesses dual core technologies categorized as "first-generation carbon reduction" and "second-generation carbon negative," with its products spanning high-growth areas such as ethanol, microbial protein, and Sustainable Aviation Fuel (SAF). Notably, its microbial protein has received the first national certificate for a new feed ingredient product in China. Additionally, its first SAF production facility, with an estimated annual capacity of approximately 50,000 tons, is scheduled to commence operations in 2027.

Prior to the IPO, the company secured strategic investments from prominent domestic and international institutions, including Caofeidian Fund, Mitsui & Co., and Shanghai Guoping. The strong margin financing activity during the first two days of the offering reflects active support from mainstream brokers and clear investor interest. Against the backdrop of ongoing policy support for carbon reduction goals and sustained interest in ESG investing, Shougang LANZA, with its unique technological advantages and clear commercialization roadmap, is likely to attract further capital inflows in the latter stages of its IPO subscription, making it a notable focus for new share investors.